Cassia Cearley - 18 Mar 2022 Form 4 Insider Report for Icosavax, Inc.

Role
Chief Business Officer
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact for Cassia Cearley
Issuer symbol
N/A
Transactions as of
18 Mar 2022
Net transactions value
+$29,515
Form type
4
Filing time
22 Mar 2022, 16:36:02 UTC
Previous filing
09 Mar 2022
Next filing
14 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICVX Common Stock Options Exercise $29,515 +35,137 +36% $0.8400* 133,550 18 Mar 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICVX Stock Option (Right to Buy) Options Exercise $0 -35,137 -56% $0.000000 27,613 18 Mar 2022 Common Stock 35,137 $0.8400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vested on 12/2/2020, and 1/48th of the shares subject to the option vest monthly thereafter.